Dr. Chamberlain has led strategic business and product development at Fortune 200, mid-sized and start-up companies for more than 20 years, including Shell Chemical, Honeywell, and Johnson Controls. Currently Dr. Chamberlain is working as a Venture Fellow with the Michigan Accelerator Fund, an early-stage venture capital fund, and with the Charter Group, as Vice President of Business Transaction Management. Before MAF and Charter, Dr. Chamberlain led global strategy and product commercialization for Global Forex Trading, helping to create corporate value which led to a $108 million acquisition of the company. Prior to this, Linda worked as Executive Director for the West Michigan Science and Technology Initiative, a business accelerator focused on commercialization of life science products and technologies, and as Executive Director for the Center for Entrepreneurship and Innovation at Grand Valley State University. She is owner and principle of InnoValuation®, a company that focuses on insuring companies have the processes and tools to extract the full value of their innovations. Dr. Chamberlain received both her BS and PhD in Chemistry from Purdue University. Dr. Chamberlain has served or is serving on the boards of MichBio, the Michigan Israel Business Bridge, Surge Medical, Clinxus, MetalFlow, Kidtelligent, and Frederik Meijer Gardens.